Treeline: Making medicines at the highest level

Treeline is a clinical-stage biopharma company with $1.1 billion in funding and three Phase 1 trials in cancer.

For Treeline we helped them develop their new brand narrative, concept for a new visual identity, and creative, direct communications strategies that generated industry media coverage without traditional PR.